Diagnosis and management of hereditary angioedema: an American approach.

[1]  K. Bork,et al.  Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. , 2003, The American journal of medicine.

[2]  A. Davis,et al.  Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. , 2002, The Journal of clinical investigation.

[3]  W. Tremaine,et al.  Hereditary angioedema: a broad review for clinicians. , 2001, Archives of internal medicine.

[4]  T. Mollnes,et al.  C1-inhibitor: an anti-inflammatory reagent with therapeutic potential , 2001, Expert opinion on pharmacotherapy.

[5]  K. Bork,et al.  Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. , 2001, Archives of internal medicine.

[6]  S. Choquet,et al.  Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema. , 2000, The Journal of allergy and clinical immunology.

[7]  K. Binkley,et al.  Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. , 2000, The Journal of allergy and clinical immunology.

[8]  K. Bork,et al.  Hereditary angioedema with normal C1-inhibitor activity in women , 2000, The Lancet.

[9]  B. Zuraw,et al.  Detection of C1 inhibitor mutations in patients with hereditary angioedema. , 2000, The Journal of allergy and clinical immunology.

[10]  K. Bork,et al.  Hepatocellular adenomas in patients taking danazol for here ditary angiooedema , 1999, The Lancet.

[11]  A. Castaldo,et al.  Successful Use of Oxandrolone in the Prophylaxis of Hereditary Angioedema: A Case Report , 1999 .

[12]  M. Cicardi,et al.  Plasma bradykinin in angio-oedema , 1998, The Lancet.

[13]  F. Rosen,et al.  Molecular defects in hereditary angioneurotic edema. , 1997, Proceedings of the Association of American Physicians.

[14]  M. Cicardi,et al.  Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. , 1997, The Journal of allergy and clinical immunology.

[15]  E. Verpy,et al.  Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema. , 1996, American journal of human genetics.

[16]  F. Rosen,et al.  Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. , 1996, The New England journal of medicine.

[17]  J. Bissler,et al.  C1- inhibitors and their genes: an update. , 1992, The Journal of laboratory and clinical medicine.

[18]  G. Audibert,et al.  Use of purified C1 esterase inhibitor in patients with hereditary angioedema. , 1990, Anesthesiology.

[19]  A. Davis.  C1 inhibitor and hereditary angioneurotic edema. , 1988, Annual review of immunology.

[20]  J. Curd,et al.  The value of rocket immunoelectrophoresis for C4 activation in the evaluation of patients with angioedema or C1-inhibitor deficiency. , 1986, The Journal of allergy and clinical immunology.

[21]  J. Curd,et al.  Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients. , 1986, The Journal of clinical investigation.

[22]  M. Greaves,et al.  Hereditary Angio-Oedema: Treatment with Cl Esterase Inhibitor Concentrate , 1984, Journal of the Royal Society of Medicine.

[23]  A. Kaplan,et al.  Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. , 1983, The Journal of allergy and clinical immunology.

[24]  R. Colman,et al.  Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. , 1983, The New England journal of medicine.

[25]  M. Cicardi,et al.  C1 INH Concentrate in the Therapy of Hereditary Angioedema , 1983, Allergy.

[26]  C. Cochrane,et al.  Detection of active kallikrein in induced blister fluids of hereditary angioedema patients , 1980, The Journal of experimental medicine.

[27]  M. Cicardi,et al.  Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate. , 1980, Annals of allergy.

[28]  J. Gelfand,et al.  Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. , 1980, The New England journal of medicine.

[29]  J. Atkinson,et al.  Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.

[30]  D. Alling,et al.  Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. , 1972, The New England journal of medicine.

[31]  F. Rosen,et al.  Hereditary Angioneurotic Edema: Two Genetic Variants , 1965, Science.

[32]  R. R. Evans,et al.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.

[33]  E. Becker,et al.  Hereditary angioneurotic edema: II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein , 1962 .

[34]  W. Spaulding.  METHYLTESTOSTERONE THERAPY FOR HEREDITARY EPISODIC EDEMA (HEREDITARY ANGIONEUROTIC EDEMA) , 1960 .

[35]  W. Osler.  HEREDITARY ANGIO‐NEUROTIC ŒDEMA , 1888 .